Correction: The Nonsteroidal Anti-Inflammatory Drug Indomethacin Induces Heterogeneity in Lipid Membranes: Potential Implication for Its Diverse Biological Action

by Yong Zhou, John F. Hancock, Lenard M. Lichtenberger
Published 2010-01-01

Correction: The Nonsteroidal Anti-Inflammatory Drug Indomethacin Induces Heterogeneity in Lipid Membranes: Potential Implication for Its Diverse Biological Action.

by Yong Zhou, John F. Hancock, Lenard M. Lichtenberger
Published 2010-01-01

The nonsteroidal anti-inflammatory drug indomethacin induces heterogeneity in lipid membranes: potential implication for its diverse biological action.

by Yong Zhou, John F Hancock, Lenard M Lichtenberger
Published 2010-01-01

RAS Nanoclusters Selectively Sort Distinct Lipid Headgroups and Acyl Chains

by Yong Zhou, Alemayehu A. Gorfe, John F. Hancock
Published 2021-06-01

Fingolimod Augments Monomethylfumarate Killing of GBM Cells

by Paul Dent, Laurence Booth, Jane L. Roberts, Andrew Poklepovic, John F. Hancock
Published 2020-01-01

Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells

by Paul Dent, Laurence Booth, Jane L. Roberts, Andrew Poklepovic, John F. Hancock
Published 2020-04-01

Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity

by Hema Adhikari, Walaa E. Kattan, Shivesh Kumar, Pei Zhou, John F. Hancock, Christopher M. Counter
Published 2021-09-01

p53 mitigates the effects of oncogenic HRAS in urothelial cells via the repression of MCOLN1

by Jewon Jung, Han Liao, Shannon A. Coker, Hong Liang, John F. Hancock, Catherine Denicourt, Kartik Venkatachalam
Published 2021-07-01

H-Ras nanocluster stability regulates the magnitude of MAPK signal output.

by Barak Rotblat, Liron Belanis, Hong Liang, Roni Haklai, Galit Elad-Zefadia, John F Hancock, Yoel Kloog, Sarah J Plowman
Published 2010-08-01

Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation

by Maja Šolman, Alessio Ligabue, Olga Blaževitš, Alok Jaiswal, Yong Zhou, Hong Liang, Benoit Lectez, Kari Kopra, Camilo Guzmán, Harri Härmä, John F Hancock, Tero Aittokallio, Daniel Abankwa
Published 2015-08-01

Discovery of High-Affinity Noncovalent Allosteric KRAS Inhibitors That Disrupt Effector Binding

by Michael J. McCarthy, Cynthia V. Pagba, Priyanka Prakash, Ali K. Naji, Dharini van der Hoeven, Hong Liang, Amit K. Gupta, Yong Zhou, Kwang-Jin Cho, John F. Hancock, Alemayehu A. Gorfe
Published 2019-02-01

Co-regulation of cell polarization and migration by caveolar proteins PTRF/Cavin-1 and caveolin-1.

by Michelle M Hill, Noor Huda Daud, Cho Sanda Aung, Dorothy Loo, Sally Martin, Samantha Murphy, Debra M Black, Rachael Barry, Fiona Simpson, Libin Liu, Paul F Pilch, John F Hancock, Marie-Odile Parat, Robert G Parton
Published 2012-01-01

Single-molecule analysis reveals self assembly and nanoscale segregation of two distinct cavin subcomplexes on caveolae

by Yann Gambin, Nicholas Ariotti, Kerrie-Ann McMahon, Michele Bastiani, Emma Sierecki, Oleksiy Kovtun, Mark E Polinkovsky, Astrid Magenau, WooRam Jung, Satomi Okano, Yong Zhou, Natalya Leneva, Sergey Mureev, Wayne Johnston, Katharina Gaus, John F Hancock, Brett M Collins, Kirill Alexandrov, Robert G Parton
Published 2014-01-01

Caveolin-1 Is Necessary for Hepatic Oxidative Lipid Metabolism: Evidence for Crosstalk between Caveolin-1 and Bile Acid Signaling

by Manuel A. Fernández-Rojo, Milena Gongora, Rebecca L. Fitzsimmons, Nick Martel, Sheree D. Martin, Susan J. Nixon, Andrew J. Brooks, Maria P. Ikonomopoulou, Sally Martin, Harriet P. Lo, Stephen A. Myers, Christina Restall, Charles Ferguson, Paul F. Pilch, Sean L. McGee, Robin L. Anderson, Michael J. Waters, John F. Hancock, Sean M. Grimmond, George E.O. Muscat, Robert G. Parton
Published 2013-07-01